PI
OMED

Putnam Investments’s OncoMed Pharmaceuticals, Inc. OMED Stock Holding History

Putnam Investments’s Portfolio OMED Stock Details OMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-38,314
Closed -$388K – 1479
2016
Q1 		$388K Buy
38,314
+244
+0.6% +$2.87K ﹤0.01% 1288
2015
Q4 		$858K Sell
38,070
-813
-2% -$16.7K ﹤0.01% 1191
2015
Q3 		$645K Buy
38,883
+1,101
+3% +$22.1K ﹤0.01% 1273
2015
Q2 		$850K Sell
37,782
-297
-0.8% -$7.32K ﹤0.01% 1256
2015
Q1 		$982K Buy
+38,079
New +$966K ﹤0.01% 1202

Other funds holding OMED

ASP
Adams Street Partners Chicago, Illinois $260M AUM 30.38% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
IHM
Iguana Healthcare Management New York $152M AUM 48.74% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Putnam Investments's OMED Position: Q2 2016 in Review

Putnam Investments sold out of OncoMed Pharmaceuticals, Inc. (OMED) in Q2 2016, closing a stake of 38,314 shares — an estimated $388K sold.

Putnam Investments first reported a position in OMED in Q1 2015 and held it in 5 quarters. The position peaked at $982K in Q1 2015. 84 funds tracked by Wall St. Rank hold OMED as of Q2 2016.

  • Putnam Investments reported no remaining OncoMed Pharmaceuticals, Inc. position as of Q2 2016 after selling out during the quarter.
  • Putnam Investments sold 38,314 OncoMed Pharmaceuticals, Inc. shares in Q2 2016, an estimated $388K.
  • Putnam Investments first reported a position in OncoMed Pharmaceuticals, Inc. in Q1 2015 and held it in 5 quarters.
  • Putnam Investments's OncoMed Pharmaceuticals, Inc. position peaked at $982K in Q1 2015.
  • 84 funds tracked by Wall St. Rank held OncoMed Pharmaceuticals, Inc. as of Q2 2016.

Based on Putnam Investments's 13F filing for Q2 2016, filed 15 Aug 2016.